Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @florubel
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @florubel
-
Florent Ubelmann proslijedio/la je Tweet
Today is not the day to ask for funds. Today is the day to take 5 min to remember those that you lost to this disease (
x100), and phone (or even better, give a hug) to those that are fighting today. #WorldCancerDay2020
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Nice article on a very promising co from
#Portugal#Lisboa Thx@Labiotech_eu#cellmabshttps://twitter.com/Labiotech_eu/status/1224310318127616000 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Florent Ubelmann proslijedio/la je Tweet
Very excited to present our latest data on tumor targeting at this conference!
#biotech@YaleCancerhttps://twitter.com/Cybrexa/status/1219267218447519744 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Florent Ubelmann proslijedio/la je Tweet
Interesting interview with Oncode Investigator
@HansClevers#outsmartingcancer#impactingliveshttps://twitter.com/TheCleversLab/status/1217438243018416129 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Florent Ubelmann proslijedio/la je Tweet
Please help spreading! My lab is hiring a postdoc in clinical proteomics, aimed at discovering biomarkers of Alzheimer's disease. See https://vibvzw.jobsoid.com/j/24865/postdoctoral-position-in-clinical-proteomics-alzheimers-disease …
@VIB_CMB@VIBLifeSciencesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Florent Ubelmann proslijedio/la je Tweet
1). END OF
#JPM20 DAY 3 Created list of most interesting PRIVATE co's Looked for those w mix of buzz-y (
) assets + public HEALTHCARE SPECIALIST investors
In Google Doc, ADDED AUDIO/SLIDES for 3 that were NOT WEBCAST: @generationbio Avidity@immatics https://docs.google.com/spreadsheets/d/1NocJQt8Vef4ALCot3GiN42osjmwUg92D-Ut4dSq9lPE/edit?usp=sharing …pic.twitter.com/ITMsH265Hf
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Fantastic resource on
#JPM20 ! If you're attending and have additional resource get in touch with@Varro_Analyticshttps://twitter.com/Varro_Analytics/status/1217716509054832640 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Florent Ubelmann proslijedio/la je Tweet
In a recent SAB that spanned "Translation" to "Basic" research I restated my belief in a "Total Science" mindset echoing the great Johan Cruyff's "Total Football".
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Florent Ubelmann proslijedio/la je Tweet
CAU GCU CCU CCU UAC AAC GAA UGG UAC GAA GCU CGU!!!
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Florent Ubelmann proslijedio/la je Tweet
Here is the programme for our next intl. course on “genome instability and human disease” that will take place on April 2020 at
@institut_curie. Check out the fantastic lineup of speakers and SAVE THE DATE!pic.twitter.com/eZg9NIO1Zs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Florent Ubelmann proslijedio/la je Tweet
“Our vision is to address
#cancer and in order to address cancer, you have to recognize that each patient is unique."@BioNTech_Group Sean Marett shared how his company navigates the#biotech fundraising Maze: http://bit.ly/370bKJX
pic.twitter.com/3yd1nxBQey
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Florent Ubelmann proslijedio/la je Tweet
Belmonte is a village in Portugal that managed to maintain itself, cryptically, Jewish throughout the Inquisition (and ever since)https://www.publico.pt/2019/12/18/fugas/noticia/belmonte-celebra-hanukkah-festa-luzes-1897826 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Florent Ubelmann proslijedio/la je Tweet
RDV le 05/02 à
#Paris ! PartneringDay@BoehringerFR@Lyonbiopole@Pole_Medicenhttps://twitter.com/BoehringerFR/status/1205052461377052673 …
1:20Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Florent Ubelmann proslijedio/la je Tweet
DRUG DEVELOPMENT FOR JUST ONE PATIENT/ her name is Mila and she has a rare disease. A therapy was developed for her in less than one year (TRIAL N=1). An amazing team achievement & the future of rare diseases... so inspiring! what a privilege to work in life sciences today
@NEJMpic.twitter.com/cAnSLSlcRD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Florent Ubelmann proslijedio/la je Tweet
A Nature Medicine Editorial "The cost of getting personal" on personalized
#antisense#oligonucleotide therapy https://rdcu.be/bYTkM pic.twitter.com/ExzPt3qJyk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Florent Ubelmann proslijedio/la je Tweet
I'll be an expert in origami by the end of this PhDhttps://twitter.com/HillLabSask/status/1204082632549715969 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great paper covering the development of the first siRNA drug! Thanks
@Alnylamhttps://twitter.com/Alnylam/status/1202659117376188419 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Florent Ubelmann proslijedio/la je Tweet
And how about aducanumab? Michael Ehlers teases plan to build the next signature genetic medicine company with $75M from Apple Tree Partnershttps://endpts.com/michael-ehlers-teases-plan-to-build-the-next-signature-genetic-medicine-company-with-75m-from-apple-tree-partners/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Florent Ubelmann proslijedio/la je Tweet
La biotech anglaise Silence Therapeutics a progressé de 1088% en 6 mois.
Elle est spécialisée dans le domaine scientifique le plus recherché en Biotech cette année : l'acide ribonucléique (ARN).pic.twitter.com/IOFxwoCPSp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
1er
Ouvert aux labos de